FDA.reportPublic FDA data

Application 010379

Type
NDA
Sponsor
KING PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CYTOMELLIOTHYRONINE SODIUMTABLET;ORALEQ 0.005MG BASEYesNo
002CYTOMELLIOTHYRONINE SODIUMTABLET;ORALEQ 0.025MG BASEYesNo
003CYTOMELLIOTHYRONINE SODIUMTABLET;ORALEQ 0.05MG BASEYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50090-0413Cytomelliothyronine sodiumA-S Medication SolutionsNDACurrent
59762-1206Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1206Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1206Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1206Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1207Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1207Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1207Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1207Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1208Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1208Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1208Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
59762-1208Liothyronine Sodiumliothyronine sodiumGreenstone LLCNDA AUTHORIZED GENERICCurrent
60793-115Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent
60793-115Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent
60793-115Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent
60793-116Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent
60793-116Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent
60793-116Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent
60793-117Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent
60793-117Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent
60793-117Cytomelliothyronine sodiumPfizer Laboratories Div Pfizer IncNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
61576SUPPL2020-01-15
57070SUPPL2018-12-31
57014SUPPL2018-12-26
33015SUPPL2002-05-17
11898SUPPL2002-05-17
217SUPPL2001-09-13